Barclays (LON:BARC) analyst Lauren Lieberman maintained a Sell rating on Clorox (NYSE:CLX) on Friday, setting a price target of $168, which is approximately 9.83% below the present share price of $186.32.
Lieberman expects Clorox to post earnings per share (EPS) of -$0.49 for the third quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Hold rating of shares in Clorox, with an average price target of $185.64.
The analysts price targets range from a high of $219 to a low of $166.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $1.78 billion and a net profit of $305 million. The company's market cap is $23.17 billion.
According to TipRanks.com, Barclays analyst Lauren Lieberman is currently ranked with 2 stars on a 0-5 stars ranking scale, with an average return of 1.1% and a 52.25% success rate.
Founded in 1913, California-based The Clorox Co . manufactures and markets consumer and professional products. It operates through four business segments: Health and Wellness, Household, Lifestyle, and International.